Gilead Sciences, Inc.

13F Filings History

Latest 13F report
Q3 2025 - Nov 13, 2025
Value $
$1.79B
Signature - Title
Andrew D. Dickinson - Executive Vice President and Chief Financial Officer
Location
Foster City, CA
Summary
This page shows a list of all the recent 13F filings made by Gilead Sciences, Inc.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Gilead Sciences, Inc. reported 9 stock holdings with total value $1.79B as of Q3 2025. Top holdings included GLPG, ACLX, RCUS, ASMB, and MRUS.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2025 9 $1.79B +$58.8M -$5.07M +$53.7M GLPG, ACLX, RCUS, ASMB, MRUS 13F-HR 11/13/2025, 04:44 PM
Q2 2025 14 $1.28B $0 -$2.42M -$2.42M GLPG, ACLX, RCUS, ASMB, TNGX 13F-HR 8/14/2025, 10:58 AM
Q1 2025 14 $1.18B +$16.5M -$9.13M +$7.38M ACLX, GLPG, RCUS, ASMB, MRUS 13F-HR 5/13/2025, 04:15 PM
Q4 2024 16 $1.55B $0 $0 ACLX, GLPG, RCUS, ASMB, MRUS 13F-HR 2/13/2025, 04:14 PM